Analyst Consensus ?
ConsensusHold44 ratings
Bullish1636.4%
Neutral2659.1%
Bearish24.5%
FN2 Earnings Intelligence
Humana Inc. analyst ratings
Humana Inc. (HUM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$365.41Current
$180Low
$384.62Average
$652High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Hold | Hold | Maintain | Jul 14, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jul 14, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Jul 13, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 9, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 7, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jun 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jun 11, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 8, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jun 8, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jun 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | May 26, 2026 |
| UBS | Neutral | Neutral | Maintain | May 22, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | May 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | May 13, 2026 |
| Guggenheim | Buy | Buy | Maintain | Apr 30, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Feb 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 12, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 5, 2025 |
| Argus Research | Hold | Hold | Maintain | Aug 14, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 25, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | May 1, 2025 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Oct 9, 2024 |
| Leerink Partners | Market Perform | Outperform | Downgrade | Oct 2, 2024 |
| SVB Securities | Outperform | Outperform | Maintain | Apr 27, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 6, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 6, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Nov 3, 2022 |
| Citigroup | Buy | Buy | Maintain | Apr 29, 2021 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | May 21, 2020 |
| BMO Capital | Market Perform | Outperform | Downgrade | Sep 30, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Aug 1, 2019 |
| Bank of America | Buy | Buy | Maintain | Aug 2, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Jan 24, 2017 |
| Stifel | Hold | Buy | Downgrade | Jan 24, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Jul 9, 2015 |
| Wedbush | Neutral | Outperform | Downgrade | Jul 6, 2015 |
| Sterne Agee CRT | Neutral | Underperform | Upgrade | Jun 3, 2015 |
| Sterne Agee | Neutral | Underperform | Upgrade | Jun 3, 2015 |
| Leerink Swann | Outperform | Outperform | Maintain | Jun 1, 2015 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 5, 2015 |
| FBR Capital | Market Perform | Market Perform | Maintain | Nov 10, 2014 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Nov 5, 2013 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Nov 5, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $365.41. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $480 | $365.45 | +31.4% | Jul 29, 2026 |
| Jefferies | Analyst unavailable | $410 | $398.25 | +12.2% | Jul 20, 2026 |
| Truist Financial | David MacDonald | $415 | $406 | +13.6% | Jul 14, 2026 |
| Wells Fargo | Stephen Baxter | $502 | $392.22 | +37.4% | Jul 13, 2026 |
| RBC Capital | Analyst unavailable | $415 | $401.34 | +13.6% | Jul 9, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $392.86 | -17.9% | Jul 7, 2026 |
| Raymond James | Sarah James | $300 | $392.86 | -17.9% | Jul 7, 2026 |
| Mizuho Securities | Analyst unavailable | $390 | $350.08 | +6.7% | Jun 8, 2026 |
| Morgan Stanley | Analyst unavailable | $249 | $327.54 | -31.9% | Jun 4, 2026 |
| Bernstein | Analyst unavailable | $425 | $320.88 | +16.3% | Jun 3, 2026 |
| Truist Financial | David MacDonald | $320 | $305.42 | -12.4% | Jun 1, 2026 |
| Barclays | Analyst unavailable | $344 | $300.86 | -5.9% | May 26, 2026 |
| UBS | Analyst unavailable | $320 | $303.68 | -12.4% | May 22, 2026 |
| Mizuho Securities | Analyst unavailable | $335 | $310.55 | -8.3% | May 20, 2026 |
| Deutsche Bank | Analyst unavailable | $441 | $310.55 | +20.7% | May 20, 2026 |
| Morgan Stanley | Erin Wright | $217 | $301.35 | -40.6% | May 15, 2026 |
| Piper Sandler | Analyst unavailable | $254 | $295.35 | -30.5% | May 13, 2026 |
| Raymond James | Analyst unavailable | $260 | $236.44 | -28.8% | May 1, 2026 |
| RBC Capital | Ben Hendrix | $246 | $240.92 | -32.7% | Apr 30, 2026 |
| Deutsche Bank | Analyst unavailable | $235 | $241.1 | -35.7% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $260 | $242.68 | -28.8% | Apr 30, 2026 |
| Truist Financial | David MacDonald | $270 | $243.12 | -26.1% | Apr 30, 2026 |
| Guggenheim | Analyst unavailable | $269 | $243.12 | -26.4% | Apr 30, 2026 |
| UBS | Analyst unavailable | $262 | $243.12 | -28.3% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $180 | $243.12 | -50.7% | Apr 30, 2026 |
| Evercore ISI | Analyst unavailable | $195 | $198.39 | -46.6% | Apr 8, 2026 |
| Mizuho Securities | Analyst unavailable | $258 | $198.39 | -29.4% | Apr 8, 2026 |
| Wells Fargo | Analyst unavailable | $206 | $184.99 | -43.6% | Feb 18, 2026 |
| Truist Financial | Analyst unavailable | $200 | $185.36 | -45.3% | Feb 17, 2026 |
| Deutsche Bank | George Hill | $180 | $182.87 | -50.7% | Feb 13, 2026 |
| UBS | Analyst unavailable | $195 | $176.24 | -46.6% | Feb 12, 2026 |
| Raymond James | Sarah James | $201 | $177.74 | -45.0% | Feb 12, 2026 |
| Oppenheimer | Analyst unavailable | $250 | $173.81 | -31.6% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $146 | $175.4 | -60.0% | Feb 12, 2026 |
| Guggenheim | Analyst unavailable | $252 | $175.4 | -31.0% | Feb 12, 2026 |
| RBC Capital | Ben Hendrix | $189 | $175.4 | -48.3% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $174 | $195.2 | -52.4% | Feb 2, 2026 |
| Wells Fargo | Analyst unavailable | $290 | $279.84 | -20.6% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $344 | $281.03 | -5.9% | Jan 6, 2026 |
| Morgan Stanley | Erin Wright | $262 | $260.28 | -28.3% | Dec 18, 2025 |
| Jefferies | David Windley | $313 | $253.02 | -14.3% | Dec 5, 2025 |
| Barclays | Andrew Mok | $234 | $229.2 | -36.0% | Nov 25, 2025 |
| Truist Financial | Analyst unavailable | $285 | $242.75 | -22.0% | Nov 10, 2025 |
| Truist Financial | Analyst unavailable | $300 | $266.92 | -17.9% | Oct 14, 2025 |
| Goldman Sachs | Scott Fidel | $235 | $271 | -35.7% | Oct 14, 2025 |
| Mizuho Securities | Ann Hynes | $345 | $298.04 | -5.6% | Oct 9, 2025 |
| Wells Fargo | Analyst unavailable | $347 | $295.2 | -5.0% | Oct 7, 2025 |
| Mizuho Securities | Analyst unavailable | $300 | $256.62 | -17.9% | Oct 3, 2025 |
| Barclays | Analyst unavailable | $245 | $256.62 | -33.0% | Oct 3, 2025 |
| Barclays | Andrew Mok | $315 | $312 | -13.8% | Sep 4, 2025 |
| Barclays | Andrew Mok | $325 | $311.98 | -11.1% | Sep 4, 2025 |
| Barclays | Andrew Mok | $275 | $261.47 | -24.7% | Jul 31, 2025 |
| Wells Fargo | Stephen Baxter | $348 | $217.14 | -4.8% | Jul 18, 2025 |
| Truist Financial | David MacDonald | $280 | $241.45 | -23.4% | Jun 17, 2025 |
| Barclays | Andrew Mok | $268 | $234.96 | -26.7% | Jun 12, 2025 |
| Deutsche Bank | George Hill | $248 | $287.64 | -32.1% | Dec 4, 2024 |
| Deutsche Bank | George Hill | $250 | $260.57 | -31.6% | Oct 22, 2024 |
| Barclays | Andrew Mok | $250 | $245.45 | -31.6% | Oct 10, 2024 |
| RBC Capital | Ben Hendrix | $265 | $236.29 | -27.5% | Oct 8, 2024 |
| Jefferies | David Windley | $253 | $240.03 | -30.8% | Oct 7, 2024 |
| Piper Sandler | Jessica Tassan | $274 | $239.32 | -25.0% | Oct 3, 2024 |
| Bank of America Securities | Kevin Fischbeck | $247 | $246.49 | -32.4% | Oct 2, 2024 |
| Jefferies | David Windley | $419 | $319.57 | +14.7% | Sep 27, 2024 |
| RBC Capital | Frank Morgan | $400 | $364.06 | +9.5% | Sep 5, 2024 |
| Oppenheimer | Michael Wiederhorn | $400 | $361.61 | +9.5% | Aug 1, 2024 |
| Truist Financial | David MacDonald | $400 | $382.22 | +9.5% | Jul 15, 2024 |
| Piper Sandler | Jessica Tassan | $392 | $355.8 | +7.3% | Jun 25, 2024 |
| Barclays | Andrew Mok | $370 | $349.55 | +1.3% | Jun 20, 2024 |
| Oppenheimer | Michael Wiederhorn | $370 | $315.98 | +1.3% | Apr 25, 2024 |
| RBC Capital | Frank Morgan | $353 | $315.98 | -3.4% | Apr 25, 2024 |
| Cantor Fitzgerald | Sarah James | $360 | $315.98 | -1.5% | Apr 25, 2024 |
| Barclays | Andrew Mok | $310 | $351.45 | -15.2% | Apr 2, 2024 |
| Truist Financial | Analyst unavailable | $560 | $474.1 | +53.3% | Feb 7, 2023 |
| Cowen & Co. | Analyst unavailable | $581 | $484.71 | +59.0% | Feb 6, 2023 |
| Credit Suisse | Analyst unavailable | $575 | $476.57 | +57.4% | Feb 6, 2023 |
| UBS | Analyst unavailable | $620 | $486.02 | +69.7% | Feb 2, 2023 |
| J.P. Morgan | Analyst unavailable | $625 | $492.54 | +71.0% | Jan 6, 2023 |
| Goldman Sachs | Nathan Rich | $652 | $528.9 | +78.4% | Dec 13, 2022 |
| Mizuho Securities | Analyst unavailable | $615 | $558.3 | +68.3% | Nov 10, 2022 |
| RBC Capital | Analyst unavailable | $544 | $505.88 | +48.9% | Sep 20, 2022 |
| Truist Financial | Analyst unavailable | $570 | $493.38 | +56.0% | Sep 16, 2022 |
| Oppenheimer | Analyst unavailable | $550 | $491.49 | +50.5% | Sep 16, 2022 |
| Morgan Stanley | Analyst unavailable | $494 | $474.44 | +35.2% | Aug 2, 2022 |
| Barclays | Analyst unavailable | $570 | $478.35 | +56.0% | Jul 28, 2022 |
| Mizuho Securities | Analyst unavailable | $529 | $478.35 | +44.8% | Jul 28, 2022 |
| Oppenheimer | Analyst unavailable | $520 | $478.35 | +42.3% | Jul 28, 2022 |
| Leerink Partners | Analyst unavailable | $540 | $478.35 | +47.8% | Jul 28, 2022 |
| Truist Financial | David MacDonald | $550 | $491.79 | +50.5% | Jul 26, 2022 |
| Wells Fargo | Analyst unavailable | $514 | $443 | +40.7% | May 25, 2022 |
| Wells Fargo | Analyst unavailable | $512 | $457.31 | +40.1% | Apr 28, 2022 |
| RBC Capital | Analyst unavailable | $541 | $442.3 | +48.1% | Apr 28, 2022 |
| Leerink Partners | Analyst unavailable | $535 | $443.37 | +46.4% | Apr 28, 2022 |
| UBS | Kevin Caliendo | $520 | $453.97 | +42.3% | Apr 19, 2022 |
| Truist Financial | David MacDonald | $490 | $451.33 | +34.1% | Apr 11, 2022 |
| UBS | Kevin Caliendo | $486 | $362.52 | +33.0% | Jan 7, 2022 |
| Barclays | Steven Valiquette | $490 | $362.52 | +34.1% | Jan 7, 2022 |
| Goldman Sachs | Nathan Rich | $472 | $460.34 | +29.2% | Dec 14, 2021 |
| Oppenheimer | Michael Wiederhorn | $510 | $452.06 | +39.6% | Nov 4, 2021 |
| Credit Suisse | A.J. Rice | $513 | $452.06 | +40.4% | Nov 4, 2021 |
| Bank of America Securities | Kevin Fischbeck | $530 | $452.06 | +45.0% | Nov 4, 2021 |
| Cantor Fitzgerald | Steven Halper | $480 | $457.94 | +31.4% | Nov 3, 2021 |
| Cowen & Co. | Gary Taylor | $479 | $415.01 | +31.1% | Sep 9, 2021 |
| Evercore ISI | Michael Newshel | $450 | $424.06 | +23.1% | Aug 4, 2021 |
| Stephens | Scott Fidel | $500 | $423.34 | +36.8% | Aug 3, 2021 |
| J.P. Morgan | Lisa Gill | $514 | $453.35 | +40.7% | Jul 9, 2021 |
| Wolfe Research | Justin Lake | $498 | $443.19 | +36.3% | Apr 26, 2021 |
Track every rating change on HUM the moment it posts. Free to start.
Start free